These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 17690553
21. Diffusion-weighted magnetic resonance imaging in diagnosis of Creutzfeldt-Jakob disease. Lou X, Ma L, An NY, Cai YQ, Liang Y, Guo XG. Chin Med J (Engl); 2006 Aug 05; 119(15):1242-7. PubMed ID: 16919182 [Abstract] [Full Text] [Related]
22. Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Cepek L, Brechlin P, Steinacker P, Mollenhauer B, Klingebiel E, Bibl M, Kretzschmar HA, Wiltfang J, Otto M. Dement Geriatr Cogn Disord; 2007 Aug 05; 23(1):22-8. PubMed ID: 17068393 [Abstract] [Full Text] [Related]
23. Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case). Pauri F, Amabile G, Fattapposta F, Pierallini A, Bianco F. Neurol Sci; 2004 Oct 05; 25(4):234-7. PubMed ID: 15549511 [Abstract] [Full Text] [Related]
24. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR. J Neurol; 2009 Sep 05; 256(9):1540-50. PubMed ID: 19418113 [Abstract] [Full Text] [Related]
25. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I. JAMA Neurol; 2015 Mar 05; 72(3):267-75. PubMed ID: 25559883 [Abstract] [Full Text] [Related]
26. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid. Collins S, Boyd A, Fletcher A, Gonzales M, McLean CA, Byron K, Masters CL. J Clin Neurosci; 2000 May 05; 7(3):203-8. PubMed ID: 10833616 [Abstract] [Full Text] [Related]
27. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI. Donahue JE, Hanna PA, Hariharan S. Neurol Sci; 2004 Feb 05; 24(6):411-3. PubMed ID: 14767688 [Abstract] [Full Text] [Related]
28. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease]. Bernheimer H, Gatterbauer B, Radbauer C, Budka H. Wien Med Wochenschr; 1998 Feb 05; 148(4):96-100. PubMed ID: 9611349 [Abstract] [Full Text] [Related]
29. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis. Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I. Neurodegener Dis; 2012 Feb 05; 9(3):139-44. PubMed ID: 22213780 [Abstract] [Full Text] [Related]
30. [Clinical typing and diagnosis of sporadic human prion diseases (classic sproadic CJD, MM2-cortical form CJD, MM2-thalamic form CJD)]. Satoh K, Shirabe S, Eguchi K. Nihon Rinsho; 2007 Aug 05; 65(8):1423-32. PubMed ID: 17695279 [Abstract] [Full Text] [Related]
31. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. Sanchez-Juan P, Sánchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichová D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I. J Neurol; 2007 Jul 05; 254(7):901-6. PubMed ID: 17385081 [Abstract] [Full Text] [Related]
33. Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD? Boesenberg-Grosse C, Schulz-Schaeffer WJ, Bodemer M, Ciesielczyk B, Meissner B, Krasnianski A, Bartl M, Heinemann U, Varges D, Eigenbrod S, Kretzschmar HA, Green A, Zerr I. BMC Neurol; 2006 Sep 21; 6():35. PubMed ID: 16989662 [Abstract] [Full Text] [Related]
34. [Serial diffusion-weighted MRI (DWI) in a patient with sporadic Creuztfeldt-Jakob disease]. Tomita I, Sato K, Shirabe S, Nagasato K, Satoh A, Tsujihata M. Rinsho Shinkeigaku; 2004 Mar 21; 44(3):182-6. PubMed ID: 15233271 [Abstract] [Full Text] [Related]
35. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. Abu Rumeileh S, Lattanzio F, Stanzani Maserati M, Rizzi R, Capellari S, Parchi P. J Alzheimers Dis; 2017 Mar 21; 55(4):1471-1480. PubMed ID: 27886009 [Abstract] [Full Text] [Related]
36. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y. Neurology; 2004 Aug 10; 63(3):443-9. PubMed ID: 15304574 [Abstract] [Full Text] [Related]
37. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease]. Sáiz A, Marín C, Tolosa E, Graus F. Neurologia; 1998 Aug 10; 13(7):324-8. PubMed ID: 9810794 [Abstract] [Full Text] [Related]
38. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA, Gefeller O, Weber T. Lancet; 1996 Sep 28; 348(9031):846-9. PubMed ID: 8826809 [Abstract] [Full Text] [Related]
39. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands]. Jansen C, Schuur M, Spliet WG, van Gool WA, van Duijn CM, Rozemuller AJ. Ned Tijdschr Geneeskd; 2009 Sep 28; 153():A172. PubMed ID: 19785859 [Abstract] [Full Text] [Related]
40. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ. J Neurol Neurosurg Psychiatry; 2010 Nov 28; 81(11):1243-8. PubMed ID: 20855493 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]